We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Advanced Melanoma

Journal Scan / Research · March 31, 2021

Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease

Annals of Internal Medicine

 

Additional Info

Annals of Internal Medicine
Safety and Efficacy of Checkpoint Inhibition in Patients With Melanoma and Preexisting Autoimmune Disease : A Cohort Study
Ann. Intern. Med 2021 Feb 16;[EPub Ahead of Print], MK van der Kooij, KPM Suijkerbuijk, MJB Aarts, FWPJ van den Berkmortel, CU Blank, MJ Boers-Sonderen, J van Breeschoten, AJM van den Eertwegh, JW B de Groot, JBAG Haanen, GAP Hospers, D Piersma, RS van Rijn, AJ Ten Tije, AAM van der Veldt, G Vreugdenhil, MCT van Zeijl, MWJM Wouters, OM Dekkers, E Kapiteijn

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading